A novel non-invasive modality for the diagnosis of PHH is based on the observation that insulinoma beta-cells have a higher density of glucagon-like peptide-1 (GLP-1) receptors (GLP-1R) [10]. This evidence concerns the gene GLP1R and pancreatic insulinoma.